用PCR-SSP法分析中国辽宁汉族HLA-DRBI基因多态性

应用PCR－SSP方法对辽宁地区159名无关个体进行HLA－DRB1位点基因分型，检出8组等位基因（扩增片段大小为100bp），基因频率范围在0．02201～0．23899。36种可能基因型中检出33种。经x2检验符合Hardy－Weinberg平衡定律。本地区汉族群体的期望杂合度为85％，观察杂合度为83％。个人鉴别机率（DP）为0．94非父排除率（EPP）为66％。本法具有简单、快速、结果可靠的特点，不仅适用于法医学亲子鉴定和个人识别、移植配型，亦可用于相关疾病及人类遗传学研究。     

HLA-DRB1位点的PCR-SSP分型在亲子鉴定中的应用研究

应用PCR－SSP（PCRamplificationwithsequencespecificprimer）方法将HLAⅡ类DRB1位点基因分型应用于亲权鉴定。对42例亲子鉴定案例进行分析研究的结果表明,本方法简单、快速、结果可靠,且具有较高的非父排除概率（66．3％）,不仅适用于法医学亲手鉴定和个人识别,亦可应用于移植配型、HLA相关疾病及人类遗传学研究。     

内蒙古中西部地区汉族、蒙古族ApoB基因遗传多态性

目的研究内蒙古中西部地区汉族、蒙古族ApoB基因遗传多态性。方法选取内蒙古中西部地区汉族、蒙古族无关个体,采用聚合酶链反应一限制性片段长度多态性技术,判断样本中是否含有ApoB基因中的稀有等位基因：XbaI（x＋）和＆DRI（E-）,并计算其基因型频率、等位基因频率及相关的群体遗传学参数。结果内蒙古汉族群体中稀有等位基因XbaI（x＋）和＆0RI（E-）频率分别为2％和4．6％,而在蒙古族群体中没有检测出此两种稀有等位基因。结论ApoB基因XbaI和＆0RI位点的等位基因频率分布在不同种族中差异较大,具有种族鉴定的应用可能。     

PCR-SSP法检验HLA-DRB基因多态性的法医学应用

HLA是迄今发现的最复杂的人类遗传标记，具有高度多态性。由于用传统的淋巴细胞毒试验检验HLA分型，对检材要求很高，因此很难应用于法医学领域中。随着分子生物学技术的迅猛发展，HLA分型已深入到基因水平。国内陆续研究报道了应用PCR一特异性寡核着酸探针（SSOP）及PCR-单链构象多态性（SSCP）对HLAⅡ类抗原的DQ－A及DQ－B等位基因进行分型，使HLA在法医学中的应用成为现实。本文应用1992年瑞典Olerup和Zetterquist首创的PCR-序列特异引物（PCR-SSP）方法对HLA－DRB基因分型在法医学中的应用进行了初探，认为在法医…     

片段长度差异等位基因特异性PCR——一种改良的SNP分型新方法

目的建立一种基于等位基因特异性PCR原理的改良SNP分型新方法:片段长度差异等位基因特异性PCR,并考察特异性引物的3'端第3位、第4位碱基错配对特异性延伸的影响。方法以SNP位点rs759117和rs760887为例,设计两条长度不同、3'末端分别与SNP两个等位基因碱基配对的上游引物,同时在两个等位基因特异性引物3'端第3或第4位碱基引入错配以增加特异性,下游为公用引物。PCR产物经聚丙烯酰胺凝胶电泳、银染显带后确定样本的基因型。结果不同SNP纯合子为长度不同的单一谱带,杂合子则为两条带,其结果与直接测序完全一致。两条特异性上游引物3'端第3或第4位碱基引入错配后非特异性延伸显著减少,且对PCR反应条件的严格性要求明显降低。结论片段长度差异等位基因特异性PCR是一种简单快速而有效的SNP分型新方法;两条特异性引物3'端第3、第4位碱基引入错配可使特异性显著增加     

2个miniSTR等位基因分型标准物的制备

目的采用分子克隆技术制备miniSTR D3S4529和D12ATA63基因座等位基因分型标准物,并评价其应用价值。方法用荧光引物对835份无关个体血卡样本进行扩增并分型检测,筛选2个基因座的等位基因片段,用分子克隆方法制备等位基因分型标准物,并对中国汉族群体进行遗传学调查。结果根据筛选出的等位基因片段制备出分型标准物,各等位基因峰形尖锐,无双肩峰,峰高基本一致,荧光值在4 000 RFU左右。中国汉族人群D3S4529、D12ATA63基因座分别检出7个、11个等位基因,杂合度分别为0.752、0.723,多态信息含量均为0.71。结论通过分子克隆法制备的miniSTR D3S4529和D12ATA63等位基因分型标准物,在法医学研究中具有较高的应用价值。     

KCNQ1内含子1a中STR基因座遗传多态性及PIA分型

目的调查汉族群体KCNQ1基因内含子1a中STR基因座的遗传多态性,并采用PIA分型技术确定等位基因的亲代来源。方法用PCR-STR分型技术对230例武汉汉族无关个体样本进行KCNQ1基因内含子1a中STR基因座分型检测;同时选用两种甲基化敏感的限制酶（msRE）HhaI和HpaⅡ对家系中孩子的基因组DNA进行消化后,采用PIA分型技术检测父源等位基因。结果KCNQ1内含子1a中STR基因座在汉族人群中检出10个等位基因、24种基因型,其个体识别能力（PD）、多态性信息含量（PIC）和非父排除率（PE）分别为0．852、0．66和0．484。HhaI和HpaII可消化个体的母源等位基因,PIA分型仅能检测出单一的父源等位基因。结论KCNQ1内含子1a中STR基因座在汉族群体具有较高的遗传多态性,PIA分型技术可以确定个体等位基因的亲代来源,具有较高的法医学应用价值。     

DNA芯片技术检测HLA-DRB1和ABO基因型

用DNA芯片技术检测HLA-DRB1-ABO基因型。根据HLA和ABO不同基因亚型的独特序列设计探针,制成分型芯片;待检测样品经PCR反应标记上荧光之后,与探针在芯片上进行杂交,通过对杂交产生的荧光信号值进行分析,确定样品DRB1位点和ABO位点的基因亚型。将这一方法应用于111份样本的HLA-DRB1-ABO基因分型并将部分样品进行基因测序。检测结果证明本实验研制的HLA-DR-ABO基因分型芯片可准确分辨出DRB1位点30个等位基因、ABO位点6种基因型。该方法分辨率高、特异性强、重复性好、操作简便,对比常规的PCR-SSP方法,HLA-DR-ABO基因芯片方法更为直观,并具有集成化优势,可以在一张芯片上同时检测HLA和ABO位点,并实现一张芯片多人份,不仅适用于法医学亲子鉴定和个体识别,亦可应用于移植配型、HLA相关疾病及人类遗传学研究。     

p33.4位点扩增片段长度多态性及其法医学应用的研究

以聚合酶链反应（PCR）、聚丙烯酰胺凝胶垂直电泳和银染法对中国100名无关个体小卫星区域p33．4位点的扩增片段长度多态性（Amp－FLPs）进行了研究，检出了8个等位基因。通过BIOTRAC系统进行数据处理．各等位基因重复单位的数目分别为7、10到15，其中在13～14之间发现一差值不足一个重复单位长度的罕见等位基因。片段长度分布于603～1115bP之间，基因频率分布于0.5～33．5％间，杂合度为64％，DP值为84．5％。对5个家庭25名相关个体进行分析，符合孟德尔遗传定律；对同一个体不同组织的DNA进行P33.4位点的分型研究表明，该技术适宜于法医物证检验。此外，本研究以Chelex处理不同检材制备DNA模板用于扩增，率先建立了比常规方法更快、更简便、更为实用的检验方法。     

3种国产化试剂盒与Identifiler^TM试剂盒检验结果比较

目的比较3种常用国产化PCR扩增试剂盒与IdentifilerTM试剂盒的检验结果。方法对455份中国汉族无关个体血样,分别用IdentifilerTM、DNA TyperTM15、GoldenEye 16BT、AGCU17＋1 4种试剂盒进行检测,对其中共有的11个基因座位分型结果进行比较,并对有差异的样本进行测序分析。结果 3种国产化试剂盒在455份样本中,发现4例样本的分型结果有差异,差异率为0.88%。其中,DNA TyperTM15试剂盒CSF1PO基因座发现1例等位基因丢失,AGCU17＋1试剂盒D18S51基因座发现1例等位基因扩增不平衡,测序结果表明,2例均系点突变导致;GoldenEye16BT试剂盒D21S11基因座发现2例假3峰型,其中1例测序未发现碱基突变,分析3峰原因可能是stutter滑脱峰所致。结论与IdentifilerTM试剂盒比较,3种国产化试剂盒均有分型差异现象,成因不同,在实践中应给予注意。     

Removal of a PCR inhibitor and resolution of DNA STR types in mixed human-canine stains from a five year old case.

The analysis of biological trace evidence from a reopened investigation into a 1991 murder from Vernon, B.C. revealed mixed human and dog bloodstains on blue jean pants that contained a PCR inhibitory substance. The presence of the inhibitory substance was detected by the inhibition caused from adding a small aliquot of the test DNA extract into a PCR reaction designed to produce a known standard product. The removal of the PCR inhibitory substance was accomplished by treating the extracted DNA with Thiopropyl Sepharose 6B beads. DNA profiles from two human contributors and a canine were obtained using species specific polymorphic STR markers. The two human DNA profiles obtained from blue jean pants were resolved, one matched the suspect and the other matched the victim. The DNA profile from the canine component matched that obtained from the known sample of the victim's dog who was also slain during the assault. This evidence along with other DNA typing evidence was critical in obtaining a resolution of the case.     

Validation and casework testing of the BioPlex-11 for STR typing of telogen hair roots

A new STR typing strategy has been developed allowing the simultaneous amplification and subsequent analysis of 11 polymorphic systems with amplicon sizes smaller than 270bp. The multiplex amplification reaction includes six STR loci from the European standard set of loci (ESS) for DNA databases (D3S1358, D8S1179, D21S11, THO1, FGA and VWA) as well as four additional STR systems selected for their robustness (D2S1338, D12S391, TPOX and D5S818) together with the sex-specific locus amelogenin. After PCR amplification, the multiplex reaction is splitted into two sets of STR multiplexes by using biotin labelled primers only for one set. Using streptavidin-coated Sepharose beads five STR systems are separated from the other six systems prior to being analysed in two different runs on a capillary gel electrophoresis instrument. The multiplex system was developed and tested especially for the use in forensic casework if only limited amounts or highly degraded DNA is available, for instance, when isolated from telogen hair roots.     

Rapid amplification of commercial STR typing kits

Forensic DNA typing is currently conducted in approximately 8–10 h. The process includes DNA extraction, quantitation, multiplex PCR amplification, and fragment length detection. Today's commercial multiplex short tandem repeat (STR) typing kits are not optimized for rapid PCR thermal cycling. Current protocols require approximately 3 h for amplifying a multiplex containing 15 STR loci plus amelogenin. With the continuing development of miniaturization technologies such as microfluidic and micro-capillary devices, there is a desire to reduce the overall time required to type DNA samples. Such miniature devices could be used for initial screening at a crime scene, at a border, and at airports. There is also the benefit of reducing the required PCR amplification time for labs typing single-source reference samples. Surveys of fast processing polymerases working in combination with rapid cycling protocols have resulted in the development of a ‘rapid’ PCR amplification protocol. Results are obtained in less than 36 min run on a standard peltier-based thermal cycler employing a heating rate of 4 °C/s. Capillary electrophoresis characterization of the PCR products indicates good peak balance between loci, strong signal intensity and minor adenylation artifacts. Genotyping results are concordant with standard amplification conditions utilizing a standard 3 h (non-rapid) thermal cycling procedure. The rapid assay conditions are robust enough to routinely amplify 0.5 ng of template DNA (with 28 cycles).     

短串联重复基因座突变率的分析研究

分析亲子鉴定案例进行中的STR基因座的突变率。采用chelex 100快速抽提DNA,DNA扩增,聚丙烯酰胺凝胶电泳、银染色法,参照标准品进行DNA分型。在300例已确定亲生关系的案例中,有11例出现STR基因座变异,其中D11S554基因座6例,D19S253基因座2例,SE33、D12S391、D13S631基因座各1例。结果提示:用STR基因座进行亲子鉴定,必须考虑STR基因座突变因素。     

Quantifiler Human DNA Quantification Kit (Applied Biosystems) as a screening kit for DNA profiling

This study investigates the connection between the results of DNA quantification with Quantifiler Human DNA Quantification Kit (AB) and DNA profiling. For this purpose the DNA concentration of 3.068 routine casework samples was determined and DNA profiling was carried out. For discussion, depending on the specific DNA concentration, the samples were divided into four groups (0–5, 5–10, 10–30 and more then 30 pg/μl DNA) and the obtained number of full or partial profiles and the negative typing results was listed. Moreover group 1 (0–5 pg/μl DNA) results were subdivided and analysed more precisely. Based on the amount of 4% positive typing results in group 1 we decided to analyse every sample with quantification results >0 pg/μl DNA. A real cut-off no longer exists. Only samples showing 0 pg/μl on each result were sorted out.     

D1S549基因座分型标准物的克隆制备方法及其群体遗传学研究

目的 采用分子克隆技术建立制备大量优质标准 STR基因座等位基因分型标准物的方法,解决长期困扰 STR分型上存在的准确性和标准化问题。方法 先用 PCR扩增出 D1S549基因座的 8个等位基因片段,将其插入 pUC重组质粒中,经 DNA测序分析证实插入片段的结构及大小,用国际标准将插入的等位基因片段进行命名,最后经转染、扩大培养,扩增及再鉴定后制备出标准的 D1S549等位基因分型标准物。结果应用此分型标准物,调查了成都地区汉族 ,甘肃回族及新疆维族群体 D1S549基因座的基因型分布频率。结论 表明该法制备的 STR基因座等位基因分型标准物适用于法医学鉴定实践, D1S549基因座是一个适合我国群体分析和法医学遗传分析的遗传标记。     

miniSTR荧光检测体系的建立及法医学应用

目的 建立检测片段均小于150bp的miniSTR荧光检测体系,提高对微量降解检材DNA的检测效能. 方法 应用Primer Premier 5软件设计、FastPCR 6.0筛选引物,组合成用四色荧光标记引物的miniSTR复合扩增体系.优化PCR检测条件和引物浓度,在3100-Avant仪上用POP4胶进行电泳检测.分型结果用DNA标准品9947A和007进行验证,并通过检测新鲜血样、疑难微量检材评估该体系的法医学应用效能.结果 建立的miniSTR荧光检测体系（D12A TA 63、D2S1776、D1GA TA 113、D4S2408、D17S974、D20S482、D3S3053、Ame logenin、D6S474、D9S1122）中各基因座的检测片段均小于150bp,各等位基因扩增均衡性良好,无非特异性扩增产物,等位基因频率分布符合Hardy-Weinberg平衡,累积个体识别率为0.999999983,三联体累积非父排除率为0.996 8.能成功检测腐败肌肉组织、低拷贝数DNA检材以及在40％甲醛溶液中固定12d的人体组织. 结论 miniSTR荧光检测体系可独立应用于降解DNA样本的个体识别鉴定或补充应用于亲权鉴定,提高对微量、降解检材DNA的检测能力.     

Whole-genome amplification by MDA to improve sensitivity of forensic expert examination of chromosomal DNA

This pilot project has the objective to evaluate the possibility of application of the multiple displacement amplification (MDA) technique to whole-genome amplification with a view to improving sensitivity of molecular-genetic test-systems. Preparations of total cellular DNA were amplified by MDA and analysed to assess conserved specificity of chromosomal DNA and its enhanced template activity in the standard polymerase chain reaction (PCR) for typing allele variants of polymorphous DNA loci. DNA samples before and after MDA showed virtually identical genotypic combinations of alleles. Allele fragments were stably detected at a level of DNA 4-5 times lower than in the standard test. The results of the study indicate that the MDA technique provides a promising tool to improve reliability of forensic- expert examination of chromosomal DNA and imply the necessity to further develop forensic-medical aspects of this method.     

PCR-STR分型技术在尿样DNA分型中的应用

目的　对尿样的DNA分型进行研究。　方法　 10份尿样随机收集于无关个体 ,同时采集血液样本做DNA分型对照 ,用PCR -STR分型技术对尿样DNA进行FIBRA和D18S5 35基因座分型。　结果　 10份尿样 10ml、1ml及 0 .2ml体积均获得准确的分型结果 ,且与同一个体的血样DNA分型结果完全相同 ;室温储存 4天及 4℃保存 4周的尿样均分型成功。　结论PCR -STR分型技术对尿样DNA分型是一种有效的方法 ,在尿样的个人识别中具有极高的实用价值。     

Results from the NIST 2004 DNA Quantitation Study

For optimal DNA short tandem repeat (STR) typing results, the DNA concentration ([DNA]) of the sample must be accurately determined prior to the polymerase chain reaction (PCR) amplification step in the typing process. In early 2004, the National Institute of Standards and Technology (NIST) conducted an interlaboratory study to help assess the accuracy of DNA quantitation in forensic DNA laboratories. This study was designed with four primary purposes: (1) to examine concentration effects and to probe performance at the lower DNA concentration levels that are frequently seen in forensic casework; (2) to examine consistency with various methodologies across multiple laboratories; (3) to examine single versus multiple source samples; and (4) to study DNA stability over time and through shipping in two types of storage tubes. Eight DNA samples of [DNA] from 0.05 ng/microL to 1.5 ng/microL were distributed. A total of 287 independent data sets were returned from 80 participants. Results were reported for 19 different DNA quantitation methodologies. Approximately 65% of the data were obtained using traditional slot blot hybridization methods; 21% were obtained using newly available quantitative real-time PCR (Q-PCR) techniques. Information from this interlaboratory study is guiding development of a future NIST Standard Reference Material for Human DNA Quantitation, SRM 2372.